Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
In: medRxiv, 2021.12.07.21267432, 9 S.
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2021
- Urheber
-
Wilhelm, Alexander
Widera, Marek
Grikscheit, Katharina
Toptan, Tuna
Schenk, Barbara
Pallas, Christiane
Metzler, Melinda
Kohmer, Niko
Hoehl, Sebastian
Helfritz, Fabian Arnold
Wolf, Timo
Götsch, Udo
Ciesek, Sandra
- DOI
-
10.1101/2021.12.07.21267432
- URN
-
urn:nbn:de:hebis:30:3-736362
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wilhelm, Alexander
- Widera, Marek
- Grikscheit, Katharina
- Toptan, Tuna
- Schenk, Barbara
- Pallas, Christiane
- Metzler, Melinda
- Kohmer, Niko
- Hoehl, Sebastian
- Helfritz, Fabian Arnold
- Wolf, Timo
- Götsch, Udo
- Ciesek, Sandra
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2021
Ähnliche Objekte (12)
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Development of antiviral strategies against positive-sense single stranded RNA viruses
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Development of antiviral strategies against positive-sense single stranded RNA viruses
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Development of antiviral strategies against positive-sense single stranded RNA viruses
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Glycoengineering of Monoclonal Antibodies